| 2023-04-21 | +108.4% | news | TradingView | Technical Analysis of Mangoceuticals, Inc. (NASDAQ:MGRX) - TradingView |
| 2023-04-21 | +108.4% | news | InvestorPlace | MGRX Stock: What Is Going on With Mangoceuticals Today? - InvestorPlace |
| 2026-03-23 | +86.3% | news | Associated Press Finance | BC-Most Active Stocks |
| 2026-03-23 | +86.3% | news | TipRanks | Why Is Mangoceuticals, Inc. Stock (MGRX) Up Today? - TipRanks |
| 2026-03-23 | +86.3% | legal | Benzinga | Mangoceuticals Stock Doubles After Texas Lawsuit - Benzinga |
| 2026-03-23 | +86.3% | executive | MEXC | Mangoceuticals (MGRX) Stock Rockets 130% Following CEO’s Substantial Share Award - MEXC |
| 2026-03-23 | +86.3% | executive | CoinCentral | Mangoceuticals (MGRX) Stock Surges 130% After CEO Lands 500K Share Bonus - CoinCentral |
| 2026-03-23 | +86.3% | news | Benzinga | Why Faraday Future Intelligent Electric Shares Are Trading Higher By Around 55%; Here Are 20 Stocks Movin - Benzinga |
| 2024-05-21 | +81.9% | news | Seeking Alpha | Microcap Mangoceuticals doubles on plan to sell cheap oral GLP-1 weight loss meds |
| 2024-05-21 | +81.9% | news | InvestorPlace | Why Is Mangoceuticals (MGRX) Stock Up 130% Today? - InvestorPlace |
| 2026-02-20 | +53.4% | news | Investing.com | Mangoceuticals stock surges on TRT program growth - Investing.com |
| 2026-02-20 | +53.4% | news | TipRanks | Here’s Why Mangoceuticals Stock (MGRX) Rocketed Today - TipRanks |
| 2026-02-20 | +53.4% | news | Benzinga | Mangoceuticals Stock Skyrockets 50% Friday: What's Driving The Rally? - Benzinga |
| 2026-02-20 | +53.4% | news | Benzinga | Mangoceuticals Stock Surges On Early Success Of Subscription TRT Model - Benzinga |
| 2026-02-20 | +53.4% | news | Meyka | MGRX (Mangoceuticals, Inc., NASDAQ) up 50.75% intraday 20 Feb 2026: TRT sales drive heavy volume - Meyka |
| 2026-02-20 | +53.4% | news | parameter.io | Mangoceuticals (MGRX) Stock Surges 70% on TRT Program Growth - parameter.io |
| 2026-02-19 | +46.8% | expansion | GlobeNewswire | MangoRx Experiences Initial Success with Newly Launched $99/month All-Inclusive Injectable Testosterone Replacement Therapy (TRT) Treatment Program |
| 2026-02-19 | +46.8% | news | Stock Titan | $99 testosterone injections give MangoRx a 336% sales surge - Stock Titan |
| 2023-12-15 | -46.5% | news | Seeking Alpha | Mangoceuticals announces pricing of $1,200,000 public offering |
| 2023-12-15 | -46.5% | news | InvestorPlace | Why Is Mangoceuticals (MGRX) Stock Down 33% Today? - InvestorPlace |
| 2025-12-18 | -42.9% | news | Seeking Alpha | Mangoceuticals prices $2.5M registered direct offering with warrants |
| 2025-12-19 | -41.5% | expansion | Seeking Alpha | Mangoceuticals launches up to $100M Solana-focused digital asset treasury |
| 2025-12-19 | -41.5% | news | Stock Titan | Why a wellness company is rolling out a $100M Solana crypto treasury - Stock Titan |
| 2023-03-22 | -38.1% | news | Seeking Alpha | Mangoceuticals stock drops nearly 20% in wake of lackluster debut |
| 2023-03-22 | -38.1% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for Mangoceuticals, Inc. (MGRX) - Zacks Investment Research |
| 2023-03-23 | -19.6% | legal | Stock Titan | Latest MGRX News - Mangoceuticals Announces Lawsuit Seeking Da... - Stock Titan |
| 2026-01-28 | -17.0% | legal | Stock Titan | [EFFECT] MANGOCEUTICALS, INC. SEC Filing - Stock Titan |
| 2026-04-18 | +16.6% | news | Cổng thông tin điện tử tỉnh Tây Ninh | Mangoceuticals (MGRX) Stock: Should You Take Exposure (Smart Money Exits) 2026-04-18 - Cash Flow - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2024-10-11 | -16.2% | news | Seeking Alpha | Mangoceuticals announces 1-for-15 reverse stock split |
| 2026-01-29 | -15.6% | news | MEXC | MGRX Price Today: Mangoceuticals, Inc. Stock Price, Quote & Chart - MEXC |
| 2023-07-26 | -14.7% | expansion | The Chronicle-Journal | Mangoceuticals (MGRX) Presents A Golden Opportunity Amid Exciting Partnerships and Dynamic Marketing Strategies - The Chronicle-Journal |
| 2024-07-11 | +14.4% | expansion | Seeking Alpha | MangoRx signs partnership for expansion into Asia Pacific, China and Latin America |
| 2023-10-20 | +14.3% | earnings | Seeking Alpha | Mangoceuticals updates on Q3 revenue growth |
| 2025-11-13 | -14.2% | news | Seeking Alpha | Lilly, Novo in pact with Mangoceuticals for direct sales of weight loss drugs |
| 2025-11-13 | -14.2% | expansion | GlobeNewswire | Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs - GlobeNewswire |
| 2025-11-13 | -14.2% | news | Stock Titan | Mangoceuticals Partners with Eli Lilly and Novo Nordisk to Deliver Affordable Access to Zepbound and Wegovy for Obesity Management - Stock Titan |
| 2025-11-13 | -14.2% | expansion | Investing.com | Mangoceuticals stock tumbles after Novo Nordisk, Lilly deny partnership claims - Investing.com |
| 2025-11-13 | -14.2% | news | StocksToTrade | Why is MGRX Soaring? Find Out Now! - StocksToTrade |
| 2025-11-13 | -14.2% | news | Stocktwits | Why Did Mangoceuticals Shares Rise Today? - Stocktwits |
| 2025-11-13 | -14.2% | M&A | TipRanks | Mangoceuticals Stock (MGRX) Soars on Deal to Sell Obesity Drugs for Eli Lilly, Novo Nordisk - TipRanks |
| 2025-11-13 | -14.2% | expansion | parameter.io | Mangoceuticals, Inc. (MGRX) Stock: Surges on Launch of Direct GLP-1 Access Programs - parameter.io |
| 2024-06-04 | +12.1% | news | Seeking Alpha | Mangoceuticals stock rallies on Japanese patent allowance |
| 2024-05-16 | +10.1% | earnings | Seeking Alpha | Mangoceuticals reports Q1 results |
| 2023-12-18 | -9.3% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2026-02-06 | +9.1% | news | Stock Titan | Mangoceuticals (MGRX) warned by Nasdaq over sub-$1 bid price and listing risk - Stock Titan |
| 2023-09-18 | -8.9% | news | Seeking Alpha | IPO Roundup: Instacart, Klaviyo and more |
| 2024-06-06 | +8.4% | news | Seeking Alpha | MangoRx gets notice of acceptance for patent application in Australia |
| 2026-03-20 | -8.3% | executive | Stock Titan | Mangoceuticals (MGRX) reprices CEO Jacob Cohen stock options to $0.45 - Stock Titan |
| 2026-03-20 | -8.3% | M&A | Stock Titan | Mangoceuticals (MGRX) CEO gets 2M options, bonus shares and trust note deal - Stock Titan |
| 2024-08-16 | -7.4% | news | Seeking Alpha | Mangoceuticals files to sell 16.17M shares of common stock for holders |
| 2024-08-16 | -7.4% | news | Seeking Alpha | Mangoceuticals reports 1H results |
| 2026-04-01 | -7.0% | news | Cổng thông tin điện tử tỉnh Tây Ninh | MGRX Stock Analysis: Mangoceuticals Inc down 2.19% to $0.35, wellness stock outlook - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2023-04-18 | -6.9% | news | CoinCodex | Mangoceuticals, Inc. (MGRX) Stock Forecast & Price Prediction 2026–2030 - CoinCodex |
| 2025-11-14 | +6.8% | expansion | Seeking Alpha | Mangoceuticals plunges after denying Lilly, Novo partnerships |
| 2025-11-14 | +6.8% | M&A | Seeking Alpha | Mangoceuticals down after denying Lilly, Novo deals (MGRX) - Seeking Alpha |
| 2025-11-14 | +6.8% | expansion | TipRanks | Investors Flee Mangoceuticals Stock (MGRX) after Eli Lilly and Novo Nordisk Deny Partnership - TipRanks |
| 2026-04-17 | +6.8% | news | StocksToTrade | Mangoceuticals Inc. (MGRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade |
| 2026-03-17 | -6.8% | legal | GlobeNewswire | Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc. |
| 2026-03-17 | -6.8% | legal | Stock Titan | Mangoceuticals Announces Lawsuit Seeking Damages Exceeding $73 Million Against Former Technology Consulting and Software Development Firm, Clarity Ventures, Inc. - Stock Titan |
| 2024-04-12 | -6.7% | M&A | Seeking Alpha | Mangoceuticals signs deal for initial development of erectile dysfunction products in Mexico |
| 2026-03-06 | -6.3% | M&A | GlobeNewswire | Mangoceuticals, Inc. Announces PCT Patent Filing for MGX-0024 Antiviral Technology to Include Inhibiting Respiratory or Orally Acquired Virus Infection in Animals or Birds |
| 2026-03-06 | -6.3% | news | Stock Titan | Zero respiratory deaths in 29,000 birds sparks global patent bid - Stock Titan |
| 2024-03-12 | -6.0% | analyst | ChartMill | MGRX Forecast, Price Target & Analyst Ratings | MANGOCEUTICALS INC (NASDAQ:MGRX) - ChartMill |
| 2024-04-23 | -5.4% | news | Seeking Alpha | Mangoceuticals files to sell 30M shares of common stock for holders |
| 2025-03-20 | +5.0% | legal | TradingView | MANGOCEUTICALS, INC. SEC 10-K Report - TradingView |
| 2025-06-13 | -4.3% | legal | Seeking Alpha | Mangoceuticals files $150M mixed securities shelf |
| 2024-05-02 | -2.6% | news | Seeking Alpha | Mangoceuticals granted 180-day extension to meet minimum bid price requirement |
| 2024-04-25 | -2.4% | M&A | Seeking Alpha | Mangoceuticals acquires a global patent portfolio |
| 2023-12-12 | -2.4% | news | Seeking Alpha | Mangoceuticals files to sell 5M shares of common stock |
| 2026-03-24 | +1.3% | news | Meyka | MGRX Mangoceuticals (NASDAQ) pre-market +99.81% Mar 24, 2026: watch heavy volume - Meyka |
| 2024-10-21 | -1.0% | legal | Seeking Alpha | Mangoceuticals refutes claims made by Lilly in weight-loss drug lawsuit |
| 2026-02-23 | -0.8% | news | GlobeNewswire | Mangoceuticals’ Patented MGX-0024 Achieves Zero Respiratory-Related Mortality in 29,000-Bird Field Trials and Demonstrates Prophylactic Benefit Against H5N1 in Controlled Government Study |
| 2026-04-09 | +0.4% | earnings | Cổng thông tin điện tử tỉnh Lào Cai | Is Mangoceuticals (MGRX) Stock Breaking Out | Price at $0.34, Up 0.30% - Pre Earnings - Cổng thông tin điện tử tỉnh Lào Cai |
| 2026-04-24 | — | news | ChartMill | MGRX Stock Price, Quote & Chart | MANGOCEUTICALS INC (NASDAQ:MGRX) - ChartMill |
| 2023-03-21 | — | news | Seeking Alpha | Mangoceuticals stock tumbles nearly 20% following $5M IPO |
| 2023-03-21 | — | news | TradingView | MGRX Stock Price and Chart — NASDAQ:MGRX - TradingView |
| 2023-03-21 | — | earnings | MarketBeat | Mangoceuticals (MGRX) Stock Price, News & Analysis - MarketBeat |